SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-13-000710
Filing Date
2013-02-06
Accepted
2013-02-06 16:06:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2212691z424b5.htm 424B5 384265
2 G148431.JPG g148431.jpg GRAPHIC 16723
  Complete submission text file 0001047469-13-000710.txt   408594
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-185647 | Film No.: 13577868
SIC: 2835 In Vitro & In Vivo Diagnostic Substances